1、 TAY D J T,SONG Y,PENG B,et al.Targeting RNA editing of antizyme inhibitor 1:A potential oligonucleotide-based antisense therapy for cancer[J].Mol Ther,2021,29(11):3258-3273. TAY D J T,SONG Y,PENG B,et al.Targeting RNA editing of antizyme inhibitor 1:A potential oligonucleotide-based antisense therapy for cancer[J].Mol Ther,2021,29(11):3258-3273.
2、 GE F,CAO X,JIANG Y.A-to-I RNA editing shows dramatic up-regulation in osteosarcoma and broadly regulates tumor-related genes by altering microRNA target regions[J].J Appl Genet,2023,64(3):493-505. GE F,CAO X,JIANG Y.A-to-I RNA editing shows dramatic up-regulation in osteosarcoma and broadly regulates tumor-related genes by altering microRNA target regions[J].J Appl Genet,2023,64(3):493-505.
3、 AMWEG A,TUSUP M,CHENG P,et al.The A to I editing landscape in melanoma and its relation to clinical outcome[J].RNA Biol,2022,19(1):996-1006. AMWEG A,TUSUP M,CHENG P,et al.The A to I editing landscape in melanoma and its relation to clinical outcome[J].RNA Biol,2022,19(1):996-1006.
4、 MARTINEZ H D,JASAVALA R J,HINKSON I,et al.RNA editing of androgen receptor gene transcripts in prostate cancer cells[J].J Biol Chem,2008,283(44):29938-29949. MARTINEZ H D,JASAVALA R J,HINKSON I,et al.RNA editing of androgen receptor gene transcripts in prostate cancer cells[J].J Biol Chem,2008,283(44):29938-29949.
5、 NAKAMURA K,SHIGEYASU K,OKAMOTO K,et al.ADAR1 and AZIN1 RNA editing function as an oncogene and contributes to immortalization in endometrial cancer[J].Gynecol Oncol,2022,166(2):326-333. NAKAMURA K,SHIGEYASU K,OKAMOTO K,et al.ADAR1 and AZIN1 RNA editing function as an oncogene and contributes to immortalization in endometrial cancer[J].Gynecol Oncol,2022,166(2):326-333.
6、 QIN J X,LIU X,WANG X L,et al.Identification and analysis of microRNA editing events in recurrent bladder cancer based on RNA sequencing:MicroRNA editing level is a potential novel biomarker[J].Front Genet,2022(13):984279. QIN J X,LIU X,WANG X L,et al.Identification and analysis of microRNA editing events in recurrent bladder cancer based on RNA sequencing:MicroRNA editing level is a potential novel biomarker[J].Front Genet,2022(13):984279.
7、 LIU Y,GUO S,XIE W,et al.Identification of microRNA editing sites in clear cell renal cell carcinoma[J].Sci Rep,2023,13(1):15117. LIU Y,GUO S,XIE W,et al.Identification of microRNA editing sites in clear cell renal cell carcinoma[J].Sci Rep,2023,13(1):15117.
8、 CHEN W,HE W,CAI H,et al.A-to-I RNA editing of BLCAP lost the inhibition to STAT3 activation in cervical cancer[J].Oncotarget,2017,8(24):39417-39429. CHEN W,HE W,CAI H,et al.A-to-I RNA editing of BLCAP lost the inhibition to STAT3 activation in cervical cancer[J].Oncotarget,2017,8(24):39417-39429.
9、 WANG B,TIAN P,SUN Q,et al.A novel,effective machine learning-based RNA editing profile for predicting the prognosis of lower-grade gliomas[J].Heliyon,2023,9(7):e18075. WANG B,TIAN P,SUN Q,et al.A novel,effective machine learning-based RNA editing profile for predicting the prognosis of lower-grade gliomas[J].Heliyon,2023,9(7):e18075.
10、 GALEANO F,ROSSETTI C,TOMASELLI S,et al.ADAR2-editing activity inhibits glioblastoma growth through the modulation of the CDC14B/Skp2/p21/p27 axis[J].Oncogene,2013,32(8):998-1009. GALEANO F,ROSSETTI C,TOMASELLI S,et al.ADAR2-editing activity inhibits glioblastoma growth through the modulation of the CDC14B/Skp2/p21/p27 axis[J].Oncogene,2013,32(8):998-1009.
11、 CHEN S C,LO C M,WANG S H,et al.RNA editing-based classification of diffuse gliomas:Predicting isocitrate dehydrogenase mutation and chromosome 1p/19q codeletion[J].BMC Bioinformatics,2019,20(Suppl 19):659. CHEN S C,LO C M,WANG S H,et al.RNA editing-based classification of diffuse gliomas:Predicting isocitrate dehydrogenase mutation and chromosome 1p/19q codeletion[J].BMC Bioinformatics,2019,20(Suppl 19):659.
12、 SILVESTRIS D A,SCOPA C,HANCHI S,et al.De novo A-to-I RNA editing discovery in lncRNA[J].Cancers,2020,12(10):2959. SILVESTRIS D A,SCOPA C,HANCHI S,et al.De novo A-to-I RNA editing discovery in lncRNA[J].Cancers,2020,12(10):2959.
13、 JIANG L,HAO Y,SHAO C,et al.ADAR1-mediated RNA editing links ganglioside catabolism to glioblastoma stem cell maintenance[J].J Clin Invest,2022,132(6):e143397. JIANG L,HAO Y,SHAO C,et al.ADAR1-mediated RNA editing links ganglioside catabolism to glioblastoma stem cell maintenance[J].J Clin Invest,2022,132(6):e143397.
14、 HWANG T,KIM S,CHOWDHURY T,et al.Genome-wide perturbations of Alu expression and Alu-associated post-transcriptional regulations distinguish oligodendroglioma from other gliomas[J].Commun Biol,2022,5(1):62. HWANG T,KIM S,CHOWDHURY T,et al.Genome-wide perturbations of Alu expression and Alu-associated post-transcriptional regulations distinguish oligodendroglioma from other gliomas[J].Commun Biol,2022,5(1):62.
15、 OKUGAWA Y,TOIYAMA Y,SHIGEYASU K,et al.Enhanced AZIN1 RNA editing and overexpression of its regulatory enzyme adar1 are important prognostic biomarkers in gastric cancer[J].J Transl Med,2018,16(1):366. OKUGAWA Y,TOIYAMA Y,SHIGEYASU K,et al.Enhanced AZIN1 RNA editing and overexpression of its regulatory enzyme adar1 are important prognostic biomarkers in gastric cancer[J].J Transl Med,2018,16(1):366.
16、 AN O,SONG Y,KE X,et al.“3G” trial:An RNA editing signature to guide gastric cancer chemotherapy[J].Cancer Res,2021,81(10):2788-2798. AN O,SONG Y,KE X,et al.“3G” trial:An RNA editing signature to guide gastric cancer chemotherapy[J].Cancer Res,2021,81(10):2788-2798.
17、 WAN J,CHEN S,ZHANG A,et al.Development and validation of a four adenosine-to-inosine RNA editing site-relevant prognostic signature for assessing survival in breast cancer patients[J].Front Oncol,2022(12):861439. WAN J,CHEN S,ZHANG A,et al.Development and validation of a four adenosine-to-inosine RNA editing site-relevant prognostic signature for assessing survival in breast cancer patients[J].Front Oncol,2022(12):861439.
18、 FUMAGALLI D,GACQUER D,ROTHé F,et al.Principles governing A-to-I RNA editing in the breast cancer transcriptome[J].Cell Rep,2015,13(2):277-289. FUMAGALLI D,GACQUER D,ROTHé F,et al.Principles governing A-to-I RNA editing in the breast cancer transcriptome[J].Cell Rep,2015,13(2):277-289.
19、 CHEN J,WANG L,WANG F,et al.Genomic identification of RNA editing through integrating omics datasets and the clinical relevance in hepatocellular carcinoma[J].Front Oncol,2020(10):37. CHEN J,WANG L,WANG F,et al.Genomic identification of RNA editing through integrating omics datasets and the clinical relevance in hepatocellular carcinoma[J].Front Oncol,2020(10):37.
20、 LEE S H,KIM H P,KANG J K,et al.Identification of diverse adenosine-to-inosine RNA editing subtypes in colorectal cancer[J].Cancer Res Treat,2017,49(4):1077-1087. LEE S H,KIM H P,KANG J K,et al.Identification of diverse adenosine-to-inosine RNA editing subtypes in colorectal cancer[J].Cancer Res Treat,2017,49(4):1077-1087.
21、 LIU Q,LI H,YOU L,et al.Genome-wide identification and analysis of A-to-I RNA editing events in the malignantly transformed cell lines from bronchial epithelial cell line induced by alpha-particles radiation[J].PLoS One,2019,14(6):e0213047. LIU Q,LI H,YOU L,et al.Genome-wide identification and analysis of A-to-I RNA editing events in the malignantly transformed cell lines from bronchial epithelial cell line induced by alpha-particles radiation[J].PLoS One,2019,14(6):e0213047.
22、 LIU L,LIU J,DENG X,et al.A nomogram based on A-to-I RNA editing predicting overall survival of patients with lung squamous carcinoma[J].BMC Cancer,2022,22(1):715. LIU L,LIU J,DENG X,et al.A nomogram based on A-to-I RNA editing predicting overall survival of patients with lung squamous carcinoma[J].BMC Cancer,2022,22(1):715.
23、 MAEMURA K,WATANABE K,ANDO T,et al.Altered editing level of microRNAs is a potential biomarker in lung adenocarcinoma[J].Cancer Sci,2018,109(10):3326-3335. MAEMURA K,WATANABE K,ANDO T,et al.Altered editing level of microRNAs is a potential biomarker in lung adenocarcinoma[J].Cancer Sci,2018,109(10):3326-3335.
24、 WANG C,HUANG M,CHEN C,et al.Identification of A-to-I RNA editing profiles and their clinical relevance in lung adenocarcinoma[J].Sci China Life Sci,2022,65(1):19-32. WANG C,HUANG M,CHEN C,et al.Identification of A-to-I RNA editing profiles and their clinical relevance in lung adenocarcinoma[J].Sci China Life Sci,2022,65(1):19-32.
25、 XU X,WANG Y,MOJUMDAR K,et al.A-to-I-edited miRNA-379-5p inhibits cancer cell proliferation through CD97-induced apoptosis[J].J Clin Invest,2019,129(12):5343-5356. XU X,WANG Y,MOJUMDAR K,et al.A-to-I-edited miRNA-379-5p inhibits cancer cell proliferation through CD97-induced apoptosis[J].J Clin Invest,2019,129(12):5343-5356.
26、 BLOW M J,GROCOCK R J,van DONGEN S,et al.RNA editing of human microRNAs[J].Genome Biol,2006,7(4):R27. BLOW M J,GROCOCK R J,van DONGEN S,et al.RNA editing of human microRNAs[J].Genome Biol,2006,7(4):R27.
27、 PAZ N,LEVANON EY,AMARIGLIO N,et al.Altered adenosine-to-inosine RNA editing in human cancer[J].Genome Res,2007,17(11):1586-1595. PAZ N,LEVANON EY,AMARIGLIO N,et al.Altered adenosine-to-inosine RNA editing in human cancer[J].Genome Res,2007,17(11):1586-1595.
28、 PINTO Y,BUCHUMENSKI I,LEVANON E Y,et al.Human cancer tissues exhibit reduced A-to-I editing of miRNAs coupled with elevated editing of their targets[J].Nucleic Acids Res,2018,46(1):71-82. PINTO Y,BUCHUMENSKI I,LEVANON E Y,et al.Human cancer tissues exhibit reduced A-to-I editing of miRNAs coupled with elevated editing of their targets[J].Nucleic Acids Res,2018,46(1):71-82.
29、 CHIGAEV M,YU H,SAMUELS D C,et al.Genomic positional dissection of RNA editomes in tumor and normal samples[J].Front Genet,2019(10):211. CHIGAEV M,YU H,SAMUELS D C,et al.Genomic positional dissection of RNA editomes in tumor and normal samples[J].Front Genet,2019(10):211.
30、 SHEN H,AN O,REN X,et al.ADARs act as potent regulators of circular transcriptome in cancer[J].Nat Commun,2022,13(1):1508. SHEN H,AN O,REN X,et al.ADARs act as potent regulators of circular transcriptome in cancer[J].Nat Commun,2022,13(1):1508.
31、 WANG Y,ZHAO J,WU J,et al.Genome-wide perturbations of A-to-I RNA editing dysregulated circular RNAs promoting the development of cervical cancer[J].Comput Biol Med,2023(166):107546. WANG Y,ZHAO J,WU J,et al.Genome-wide perturbations of A-to-I RNA editing dysregulated circular RNAs promoting the development of cervical cancer[J].Comput Biol Med,2023(166):107546.
32、 ZIPETO M A,COURT A C,SADARANGANI A,et al.ADAR1 activation drives leukemia stem cell self-renewal by impairing let-7 biogenesis[J].Cell Stem Cell,2016,19(2):177-191. ZIPETO M A,COURT A C,SADARANGANI A,et al.ADAR1 activation drives leukemia stem cell self-renewal by impairing let-7 biogenesis[J].Cell Stem Cell,2016,19(2):177-191.
33、 YANG W,CHENDRIMADA T P,WANG Q,et al.Modulation of microRNA processing and expression through RNA editing by ADAR deaminases[J].Nat Mol Biol,2006,13(1):13-21. YANG W,CHENDRIMADA T P,WANG Q,et al.Modulation of microRNA processing and expression through RNA editing by ADAR deaminases[J].Nat Mol Biol,2006,13(1):13-21.
34、 TOMASELLI S,GALEANO F,ALON S,et al.Modulation of microRNA editing,expression and processing by ADAR2 deaminase in glioblastoma[J].Genome Biol,2015,16(1):5. TOMASELLI S,GALEANO F,ALON S,et al.Modulation of microRNA editing,expression and processing by ADAR2 deaminase in glioblastoma[J].Genome Biol,2015,16(1):5.
35、 LIU W H,CHEN C H,YEH K H,et al.ADAR2-mediated editing of miR-214 and miR-122 precursor and antisense RNA transcripts in liver cancers[J].PLoS One,2013,8(12):e81922. LIU W H,CHEN C H,YEH K H,et al.ADAR2-mediated editing of miR-214 and miR-122 precursor and antisense RNA transcripts in liver cancers[J].PLoS One,2013,8(12):e81922.
36、 SOLOMON O,DI SEGNI A,CESARKAS K,et al.RNA editing by ADAR1 leads to context-dependent transcriptome-wide changes in RNA secondary structure[J].Nat Commun,2017,8(1):1440. SOLOMON O,DI SEGNI A,CESARKAS K,et al.RNA editing by ADAR1 leads to context-dependent transcriptome-wide changes in RNA secondary structure[J].Nat Commun,2017,8(1):1440.
37、 CHEN Y T,CHANG I Y,LIU H,et al.Tumor-associated intronic editing of HNRPLL generates a novel splicing variant linked to cell proliferation[J].J Biol Chem,2018,293(26):10158-10171. CHEN Y T,CHANG I Y,LIU H,et al.Tumor-associated intronic editing of HNRPLL generates a novel splicing variant linked to cell proliferation[J].J Biol Chem,2018,293(26):10158-10171.
38、 LI J,LI Q,YU C P,et al.Genome-wide expression changes mediated by A-to-I RNA editing correlate with hepatic oncogenesis[J].Transl Cancer Res,2021,10(6):2725-2737. LI J,LI Q,YU C P,et al.Genome-wide expression changes mediated by A-to-I RNA editing correlate with hepatic oncogenesis[J].Transl Cancer Res,2021,10(6):2725-2737.
39、 SOLOMON O,OREN S,SAFRAN M,et al.Global regulation of alternative splicing by adenosine deaminase acting on RNA(ADAR)[J].RNA,2013,19(5):591-604. SOLOMON O,OREN S,SAFRAN M,et al.Global regulation of alternative splicing by adenosine deaminase acting on RNA(ADAR)[J].RNA,2013,19(5):591-604.
40、 GONCHAROV A O,SHENDER V O,KUZNETSOVA KG,et al.Interplay between A-to-I editing and splicing of RNA:A potential point of application for cancer therapy[J].Int J Mol Sci,2022,23(9):5240. GONCHAROV A O,SHENDER V O,KUZNETSOVA KG,et al.Interplay between A-to-I editing and splicing of RNA:A potential point of application for cancer therapy[J].Int J Mol Sci,2022,23(9):5240.
41、 WONG T-L,LOH J-J,LU S,et al.ADAR1-mediated RNA editing of SCD1 drives drug resistance and self-renewal in gastric cancer[J].Nat Commun,2023,14(1):2861. WONG T-L,LOH J-J,LU S,et al.ADAR1-mediated RNA editing of SCD1 drives drug resistance and self-renewal in gastric cancer[J].Nat Commun,2023,14(1):2861.
42、 WANG Q,HUI H,GUO Z,et al.ADAR1 regulates ARHGAP26 gene expression through RNA editing by disrupting miR-30b-3p and miR-573 binding[J].RNA,2013,19(11):1525-1536. WANG Q,HUI H,GUO Z,et al.ADAR1 regulates ARHGAP26 gene expression through RNA editing by disrupting miR-30b-3p and miR-573 binding[J].RNA,2013,19(11):1525-1536.
43、 NAKANO M,FUKAMI T,GOTOH S,et al.A-to-I RNA editing up-regulates human dihydrofolate reductase in breast cancer[J]. J Biol Chem,2017,292(12):4873-4884. NAKANO M,FUKAMI T,GOTOH S,et al.A-to-I RNA editing up-regulates human dihydrofolate reductase in breast cancer[J]. J Biol Chem,2017,292(12):4873-4884.
44、 CHO CJ,JUNG J,JIANG L,et al.Combinatory RNA-sequencing analyses reveal a dual mode of gene regulation by ADAR1 in gastric cancer[J].Dig Dis Sci,2018,63(7):1835-1850. CHO CJ,JUNG J,JIANG L,et al.Combinatory RNA-sequencing analyses reveal a dual mode of gene regulation by ADAR1 in gastric cancer[J].Dig Dis Sci,2018,63(7):1835-1850.
45、 JIANG Q,ISQUITH J,ZIPETO M A,et al.Hyper-editing of cell-cycle regulatory and tumor suppressor RNA promotes malignant progenitor propagation[J].Cancer Cell,2019,35(1):81-94.e7. JIANG Q,ISQUITH J,ZIPETO M A,et al.Hyper-editing of cell-cycle regulatory and tumor suppressor RNA promotes malignant progenitor propagation[J].Cancer Cell,2019,35(1):81-94.e7.
46、 LI Y,WANG N,YIN C,et al.RNA editing enzyme ADAR1 regulates METTL3 in an editing dependent manner to promote breast cancer progression via METTL3/ARHGAP5/YTHDF1 axis[J].Int J Mol Sci,2022,23(17):9656. LI Y,WANG N,YIN C,et al.RNA editing enzyme ADAR1 regulates METTL3 in an editing dependent manner to promote breast cancer progression via METTL3/ARHGAP5/YTHDF1 axis[J].Int J Mol Sci,2022,23(17):9656.
47、 SHOSHAN E,MOBLEY A K,BRAEUER R R,et al.Reduced adenosine-to-inosine miR-455-5p editing promotes melanoma growth and metastasis[J].Nat Biol,2015,17(3):311-321. SHOSHAN E,MOBLEY A K,BRAEUER R R,et al.Reduced adenosine-to-inosine miR-455-5p editing promotes melanoma growth and metastasis[J].Nat Biol,2015,17(3):311-321.
48、 VELAZQUEZ-TORRES G,SHOSHAN E,IVAN C,et al.A-to-I miR-378a-3p editing can prevent melanoma progression via regulation of PARVA expression[J].Nat Commun,2018,9(1):461. VELAZQUEZ-TORRES G,SHOSHAN E,IVAN C,et al.A-to-I miR-378a-3p editing can prevent melanoma progression via regulation of PARVA expression[J].Nat Commun,2018,9(1):461.
49、 ROMANO G,LE P,NIGITA G,et al.A-to-I edited miR-411-5p targets MET and promotes TKI response in NSCLC-resistant cells[J].Oncogene,2023,42(19):1597-1606. ROMANO G,LE P,NIGITA G,et al.A-to-I edited miR-411-5p targets MET and promotes TKI response in NSCLC-resistant cells[J].Oncogene,2023,42(19):1597-1606.
50、 CHOUDHURY Y,TAY F C,LAM D H,et al.Attenuated adenosine-to-inosine editing of microRNA-376a* promotes invasiveness of glioblastoma cells[J].J Clin Invest,2012,122(11):4059-4076. CHOUDHURY Y,TAY F C,LAM D H,et al.Attenuated adenosine-to-inosine editing of microRNA-376a* promotes invasiveness of glioblastoma cells[J].J Clin Invest,2012,122(11):4059-4076.
51、 CESARINI V,SILVESTRIS D A,TASSINARI V,et al.ADAR2/miR-589-3p axis controls glioblastoma cell migration/invasion[J].Nucleic Acids Res,2018,46(4):2045-2059. CESARINI V,SILVESTRIS D A,TASSINARI V,et al.ADAR2/miR-589-3p axis controls glioblastoma cell migration/invasion[J].Nucleic Acids Res,2018,46(4):2045-2059.
52、 RAMíREZ-MOYA J,BAKER A R,SLACK F J,et al.ADAR1-mediated RNA editing is a novel oncogenic process in thyroid cancer and regulates miR-200 activity[J].Oncogene,2020,39(18):3738-3753. RAMíREZ-MOYA J,BAKER A R,SLACK F J,et al.ADAR1-mediated RNA editing is a novel oncogenic process in thyroid cancer and regulates miR-200 activity[J].Oncogene,2020,39(18):3738-3753.
53、 WANG Y,XU X,YU S,et al.Systematic characterization of A-to-I RNA editing hotspots in microRNAs across human cancers[J].Genome Res,2017,27(7):1112-1125. WANG Y,XU X,YU S,et al.Systematic characterization of A-to-I RNA editing hotspots in microRNAs across human cancers[J].Genome Res,2017,27(7):1112-1125.
54、 SOLER M,DAVALOS V,SáNCHEZ-CASTILLO A,et al.The transcribed ultraconserved region uc.160+ enhances processing and A-to-I editing of the miR-376 cluster:Hypermethylation improves glioma prognosis[J].Mol Oncol,2022,16(3):648-664. SOLER M,DAVALOS V,SáNCHEZ-CASTILLO A,et al.The transcribed ultraconserved region uc.160+ enhances processing and A-to-I editing of the miR-376 cluster:Hypermethylation improves glioma prognosis[J].Mol Oncol,2022,16(3):648-664.
55、 KIM H S,NA M J,SON K H,et al.ADAR1-dependent miR-3144-3p editing simultaneously induces MSI2 expression and suppresses SLC38A4 expression in liver cancer[J].Exp Mol Med,2023,55(1):95-107. KIM H S,NA M J,SON K H,et al.ADAR1-dependent miR-3144-3p editing simultaneously induces MSI2 expression and suppresses SLC38A4 expression in liver cancer[J].Exp Mol Med,2023,55(1):95-107.
56、 ZHOU C,WEI Z,ZHANG L,et al.Systematically characterizing A-to-I RNA editing neoantigens in cancer[J].Front Oncol,2020(10):593989. ZHOU C,WEI Z,ZHANG L,et al.Systematically characterizing A-to-I RNA editing neoantigens in cancer[J].Front Oncol,2020(10):593989.
57、 HAN F,HU M,ZHANG L,et al.A-to-I RNA editing of BLCAP promotes cell proliferation by losing the inhibitory of Rb1 in colorectal cancer[J].Exp Cell Res,2022,417(2):113209. HAN F,HU M,ZHANG L,et al.A-to-I RNA editing of BLCAP promotes cell proliferation by losing the inhibitory of Rb1 in colorectal cancer[J].Exp Cell Res,2022,417(2):113209.
58、 LI H,WANG J,TU J.A-to-I nonsynonymous RNA editing was significantly enriched in the ubiquitination site and correlated with clinical features and immune response[J].Sci Rep,2022,12(1):15079. LI H,WANG J,TU J.A-to-I nonsynonymous RNA editing was significantly enriched in the ubiquitination site and correlated with clinical features and immune response[J].Sci Rep,2022,12(1):15079.
59、 HAN S W,KIM H P,SHIN J Y,et al.RNA editing in RHOQ promotes invasion potential in colorectal cancer[J].J Exp Med,2014,211(4):613-621. HAN S W,KIM H P,SHIN J Y,et al.RNA editing in RHOQ promotes invasion potential in colorectal cancer[J].J Exp Med,2014,211(4):613-621.
60、 GUMIREDDY K,LI A,KOSSENKOV A V,et al.The mRNA-edited form of GABRA3 suppresses GABRA3-mediated Akt activation and breast cancer metastasis[J].Nat Commun,2016(7):10715. GUMIREDDY K,LI A,KOSSENKOV A V,et al.The mRNA-edited form of GABRA3 suppresses GABRA3-mediated Akt activation and breast cancer metastasis[J].Nat Commun,2016(7):10715.
61、 CHEN Y B,LIAO X Y,ZHANG J B,et al.ADAR2 functions as a tumor suppressor via editing IGFBP7 in esophageal squamous cell carcinoma[J].Int J Oncol,2017,50(2):622-630. CHEN Y B,LIAO X Y,ZHANG J B,et al.ADAR2 functions as a tumor suppressor via editing IGFBP7 in esophageal squamous cell carcinoma[J].Int J Oncol,2017,50(2):622-630.
62、 FU L,QIN Y R,MING X Y,et al.RNA editing of SCL22A3 drives early tumor invasion and metastasis in familial esophageal cancer[J].Proc Natl Acad Sci U S A,2017,114(23):E4631-E4640. FU L,QIN Y R,MING X Y,et al.RNA editing of SCL22A3 drives early tumor invasion and metastasis in familial esophageal cancer[J].Proc Natl Acad Sci U S A,2017,114(23):E4631-E4640.
63、 TEOH P J,AN O,CHUNG T H,et al.Aberrant hyperediting of the myeloma transcriptome by ADAR1 confers oncogenicity and is a marker of poor prognosis[J].Blood,2018,132(12):1304-1317. TEOH P J,AN O,CHUNG T H,et al.Aberrant hyperediting of the myeloma transcriptome by ADAR1 confers oncogenicity and is a marker of poor prognosis[J].Blood,2018,132(12):1304-1317.
64、 ZHANG Y,WANG K,ZHAO Z,et al.ADAR3 expression is an independent prognostic factor in lower-grade diffuse gliomas and positively correlated with the editing level of GRIA2Q607R[J].Cancer Cell Int,2018(18):196. ZHANG Y,WANG K,ZHAO Z,et al.ADAR3 expression is an independent prognostic factor in lower-grade diffuse gliomas and positively correlated with the editing level of GRIA2Q607R[J].Cancer Cell Int,2018(18):196.
65、 SILVESTRIS DA,PICARDI E,CESARINI V,et al.Dynamic inosinome profiles reveal novel patient stratification and gender-specific differences in glioblastoma[J].Genome Biol,2019,20(1):33. SILVESTRIS DA,PICARDI E,CESARINI V,et al.Dynamic inosinome profiles reveal novel patient stratification and gender-specific differences in glioblastoma[J].Genome Biol,2019,20(1):33.
66、 HAN J,AN O,HONG H,et al.Suppression of adenosine-to-inosine(A-to-I)RNA editome by death associated protein 3(DAP3)promotes cancer progression[J].Sci Adv,2020,6(25):eaba5136. HAN J,AN O,HONG H,et al.Suppression of adenosine-to-inosine(A-to-I)RNA editome by death associated protein 3(DAP3)promotes cancer progression[J].Sci Adv,2020,6(25):eaba5136.
67、 SHEN P,YANG T,CHEN Q,et al.CircNEIL3 regulatory loop promotes pancreatic ductal adenocarcinoma progression via mirna sponging and A-to-I RNA-editing[J].Mol Cancer,2021,20(1):51. SHEN P,YANG T,CHEN Q,et al.CircNEIL3 regulatory loop promotes pancreatic ductal adenocarcinoma progression via mirna sponging and A-to-I RNA-editing[J].Mol Cancer,2021,20(1):51.
68、 RAMíREZ-MOYA J,MILIOTIS C,BAKER A R,et al.An ADAR1-dependent RNA editing event in the cyclin-dependent kinase CDK13 promotes thyroid cancer hallmarks[J].Mol Cancer,2021,20(1):115. RAMíREZ-MOYA J,MILIOTIS C,BAKER A R,et al.An ADAR1-dependent RNA editing event in the cyclin-dependent kinase CDK13 promotes thyroid cancer hallmarks[J].Mol Cancer,2021,20(1):115.
69、 BAKER A R,MILIOTIS C,RAMíREZ-MOYA J,et al.Transcriptome profiling of ADAR1 targets in triple-negative breast cancer cells reveals mechanisms for regulating growth and invasion[J].Mol Cancer Res,2022,20(6):960-971. BAKER A R,MILIOTIS C,RAMíREZ-MOYA J,et al.Transcriptome profiling of ADAR1 targets in triple-negative breast cancer cells reveals mechanisms for regulating growth and invasion[J].Mol Cancer Res,2022,20(6):960-971.
70、 CHEN K J,HUANG J H,SHIH J H,et al.Somatic A-to-I RNA-edited RHOA isoform 2 specific-R176G mutation promotes tumor progression in lung adenocarcinoma[J].Mol Carcinog,2023,62(3):348-359. CHEN K J,HUANG J H,SHIH J H,et al.Somatic A-to-I RNA-edited RHOA isoform 2 specific-R176G mutation promotes tumor progression in lung adenocarcinoma[J].Mol Carcinog,2023,62(3):348-359.
71、 GAO C,ZHOU G,SHI J,et al.The A-to-I editing of KPC1 promotes intrahepatic cholangiocarcinoma by attenuating proteasomal processing of NF-κB1 p105 to p50[J].J Exp Clin Cancer Res,2022,41(1):338. GAO C,ZHOU G,SHI J,et al.The A-to-I editing of KPC1 promotes intrahepatic cholangiocarcinoma by attenuating proteasomal processing of NF-κB1 p105 to p50[J].J Exp Clin Cancer Res,2022,41(1):338.
72、 CHAN T H,LIN C H,QI L,et al.A disrupted RNA editing balance mediated by ADARs(Adenosine DeAminases that act on RNA)in human hepatocellular carcinoma[J].Gut,2014,63(5):832-843. CHAN T H,LIN C H,QI L,et al.A disrupted RNA editing balance mediated by ADARs(Adenosine DeAminases that act on RNA)in human hepatocellular carcinoma[J].Gut,2014,63(5):832-843.
73、 SONG Y,AN O,REN X,et al.RNA editing mediates the functional switch of COPA in a novel mechanism of hepatocarcinogenesis[J].J Hepatol,2021,74(1):135-147. SONG Y,AN O,REN X,et al.RNA editing mediates the functional switch of COPA in a novel mechanism of hepatocarcinogenesis[J].J Hepatol,2021,74(1):135-147.
74、 WANG S,ZHANG L,CHEN G,et al.COPA A-to-I RNA editing hijacks endoplasmic reticulum stress to promote metastasis in colorectal cancer[J].Cancer Lett,2023(553):215995. WANG S,ZHANG L,CHEN G,et al.COPA A-to-I RNA editing hijacks endoplasmic reticulum stress to promote metastasis in colorectal cancer[J].Cancer Lett,2023(553):215995.
75、 PENG X,XU X,WANG Y,et al.A-to-I RNA editing contributes to proteomic diversity in cancer[J].Cancer Cell,2018,33(5):817-828. PENG X,XU X,WANG Y,et al.A-to-I RNA editing contributes to proteomic diversity in cancer[J].Cancer Cell,2018,33(5):817-828.
76、 QIN Y R,QIAO J J,CHAN T H,et al.Adenosine-to-inosine RNA editing mediated by ADASs in esophageal squamous cell carcinoma[J].Cancer Res,2014,74(3):840-851. QIN Y R,QIAO J J,CHAN T H,et al.Adenosine-to-inosine RNA editing mediated by ADASs in esophageal squamous cell carcinoma[J].Cancer Res,2014,74(3):840-851.
77、 HAN L,DIAO L,YU S,et al.The genomic landscape and clinical relevance of A-to-I RNA editing in human cancers[J].Cancer Cell,2015,28(4):515-528. HAN L,DIAO L,YU S,et al.The genomic landscape and clinical relevance of A-to-I RNA editing in human cancers[J].Cancer Cell,2015,28(4):515-528.
78、 SHIGEYASU K,OKUGAWA Y,TODEN S,et al.AZIN1 RNA editing confers cancer stemness and enhances oncogenic potential in colorectal cancer[J].JCI insight,2018,3(12):e99976. SHIGEYASU K,OKUGAWA Y,TODEN S,et al.AZIN1 RNA editing confers cancer stemness and enhances oncogenic potential in colorectal cancer[J].JCI insight,2018,3(12):e99976.
79、 TAKEDA S,SHIGEYASU K,OKUGAWA Y,et al.Activation of AZIN1 RNA editing is a novel mechanism that promotes invasive potential of cancer-associated fibroblasts in colorectal cancer[J].Cancer Lett,2019(444):127-135. TAKEDA S,SHIGEYASU K,OKUGAWA Y,et al.Activation of AZIN1 RNA editing is a novel mechanism that promotes invasive potential of cancer-associated fibroblasts in colorectal cancer[J].Cancer Lett,2019(444):127-135.
80、 WEI Y,ZHANG H,FENG Q,et al.A novel mechanism for A-to-I RNA-edited AZIN1 in promoting tumor angiogenesis in colorectal cancer[J].Cell Death Dis,2022,13(4):294. WEI Y,ZHANG H,FENG Q,et al.A novel mechanism for A-to-I RNA-edited AZIN1 in promoting tumor angiogenesis in colorectal cancer[J].Cell Death Dis,2022,13(4):294.
81、 PAZ-YAACOV N,BAZAK L,BUCHUMENSKI I,et al.ElevatedRNA editing activity is a major contributor to transcriptomic diversity in tumors[J].Cell Rep,2015,13(2):267-276. PAZ-YAACOV N,BAZAK L,BUCHUMENSKI I,et al.ElevatedRNA editing activity is a major contributor to transcriptomic diversity in tumors[J].Cell Rep,2015,13(2):267-276.
82、 PENG X,XU X,WANG Y,et al.A-to-I RNA editing contributes to proteomic diversity in cancer[J].Cancer Cell,2018,33(5):817-828 e7. PENG X,XU X,WANG Y,et al.A-to-I RNA editing contributes to proteomic diversity in cancer[J].Cancer Cell,2018,33(5):817-828 e7.
83、 GANEM N S,BEN-ASHER N,LAMM A T.In cancer,A-to-I RNA editing can be the driver,the passenger,or the mechanic[J].Drug Resist Updat,2017(32):16-22. GANEM N S,BEN-ASHER N,LAMM A T.In cancer,A-to-I RNA editing can be the driver,the passenger,or the mechanic[J].Drug Resist Updat,2017(32):16-22.
84、 HANAHAN D.Hallmarks of cancer:New dimensions[J].Cancer Discov 2022,12(1):31-46. HANAHAN D.Hallmarks of cancer:New dimensions[J].Cancer Discov 2022,12(1):31-46.
85、 BAYSAL B E,SHARMA S,HASHEMIKHABIR S,et al.RNA editing in pathogenesis of cancer[J].Cancer Res,2017,77(14):3733-3739. BAYSAL B E,SHARMA S,HASHEMIKHABIR S,et al.RNA editing in pathogenesis of cancer[J].Cancer Res,2017,77(14):3733-3739.
86、 BARLESI F,MAZIERES J,MERLIO J P,et al.Routine molecular profiling of patients with advanced non-small-cell lung cancer:Results of a 1-year nationwide programme of the french cooperative thoracic intergroup(ifct)[J].Lancet,2016,387(10026):1415-1426. BARLESI F,MAZIERES J,MERLIO J P,et al.Routine molecular profiling of patients with advanced non-small-cell lung cancer:Results of a 1-year nationwide programme of the french cooperative thoracic intergroup(ifct)[J].Lancet,2016,387(10026):1415-1426.
